Press release
Phenylbutazone Market: Global Industry Trend Analysis 2012 to 2017 and Forecast 2017 - 2025
Phenylbutazone is a nonsteroidal anti-inflammatory drug (NSAID) for the short-term treatment of fever and pain in animals. In the UK and the U.S., it is no longer approved for human use, as it can cause severe adverse effects such as aplastic anemia and suppression of white blood cell production. Phenylbutazone was originally used in humans for the treatment of gout and rheumatoid arthritis in 1949. Phenylbutazone is commonly used in horses for the following purposes: Antipyresis and Analgesia. Phenylbutazone is used for pain relief from musculoskeletal disorders including overuse injuries, sprains, tendinitis, arthralgias, laminitis and arthritis and relief from infection. Phenylbutazone acts directly on musculoskeletal tissue to control inflammation, thereby alleviating pain, and restoring range of motion.Report Overview @ https://www.persistencemarketresearch.com/market-research/phenylbutazone-market.asp
Phenylbutazone can be administered intravenously or orally (via powder, paste or feed-in). Phenylbutazone should not be injected in any place other than a vein and administered intramuscularly. Edema and tissue damage may also occur if the drug is injected repetitively into the same vein. Side effects of phenylbutazone include blood dyscrasia, GI ulcers, oral lesions, kidney damage and internal hemorrhage. Phenylbutazone should not be used in combination with vitamin K antagonists such as warfarin as it amplifies the anticoagulant effect of these drugs. Phenylbutazone displaces warfarin from toxic blood levels and plasma binding sites leading to haemorrhage.
The growth in end user industries is expected to increase demand for phenylbutazone. The growth in veterinary medicine industry is expected to increase consumption of phenylbutazone. In addition, rising demand for non steroidal anti-inflammatory drugs from emerging economies of Asia Pacific and Latin America is expected to boost demand for phenylbutazone. However, availability of substitutes and government regulations could hamper the growth of this market. Harpagophytum can replace phenylbutazone for treatment of fever and pain in horses.
Request for Table of Contents @ https://www.persistencemarketresearch.com/toc/20644
Asia Pacific is expected to be the largest consumer of phenylbutazone followed by North America and Europe. China and India are the major consumers of phenylbutazone in Asia Pacific due to presence of established end user industries. Phenylbutazone manufacturers are shifting their base to emerging economies of Asia Pacific due to availability of government subsidies, land and cheap labor. Mongolia, Republic of Korea, Australia and New Zealand are expected to be other major consumers of phenylbutazone in Asia Pacific. North America and Europe are expected to experience moderate to high growth. In addition, demand for phenylbutazone is expected to increase in emerging economies of Latin America due to increasing demand for veterinary drugs. Argentina, Brazil, Colombia and Peru are major consumers of phenylbutazone in Latin America.
Get Sample Copy of this Report @ https://www.persistencemarketresearch.com/samples/20644
The market is dominated by large and medium chemical and pharmaceutical corporations. Some of the key players in this market are Santa Cruz Biotechnology, Inc. (U.S.), Hangzhou Hyper Chemicals Limited (China), Baoji Guokang Bio-Technology Co., Ltd.(China), Wuhan Yitongtai Science and Technology Co., Ltd. (China), Afine Chemicals Limited (china), Shanghai Win-Win Biochemical Co., Ltd. (china), Shaanxi TOP Pharm Chemical Co., Ltd.(China), Hangzhou Hyper Chemicals Limited (China), Hangzhou Ruijiang Chemical Co., Ltd. (China), Dalian Launcher Fine Chemical Co., Ltd.(China), Croma Life Science Pvt. Ltd (India), Swati Chemicals (India), Suchem Laboratories (India), Uni-med India (India), Afton Pharma (India) and Hefei TNJ Chemical Industry Co., Ltd. (China) among others. Companies are using strategic acquisitions and mergers to remain competitive in the market. In addition, companies are increasing their presence in emerging economies of Latin America and Europe to increase their market presence.
Need more information about Report methodology ? @ https://www.persistencemarketresearch.com/methodology/20644
About Us
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.
Contact Us
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA,Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: https://www.persistencemarketresearch.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Phenylbutazone Market: Global Industry Trend Analysis 2012 to 2017 and Forecast 2017 - 2025 here
News-ID: 957377 • Views: …
More Releases from Persistence Market Research
Polyester Medical Films Market to Reach US$ 2.9 Billion by 2032 - Persistence Ma …
The global polyester medical films market is evolving rapidly, driven by the rising demand for advanced medical devices, diagnostic applications, and innovative packaging solutions. Polyester medical films have become a preferred material in healthcare because of their excellent strength, clarity, chemical resistance, and biocompatibility. As the healthcare sector continues to expand globally, these films play a crucial role in improving product performance, shelf life, and patient safety.
Get a Sample PDF…
Europe Biostimulants Market to Hit US$3.1 Billion by 2032 Driven by Sustainable …
The Europe Biostimulants Market is witnessing remarkable growth, driven by increasing adoption of sustainable agricultural practices, the growing emphasis on organic farming, and rising awareness about crop productivity enhancement through natural solutions. According to the latest study by Persistence Market Research, the market is valued at US$1.4 billion in 2025 and is projected to reach US$3.1 billion by 2032, expanding at a robust CAGR of 12.4% during the forecast period.…
Nanomaterials Market Valued at US$ 22.1 Billion in 2025, Poised to Reach US$ 69. …
The nanomaterials market has entered a phase of accelerated commercialization, driven by technological maturity and growing demand across sectors. The market's rapid expansion is supported by rising investments in research and development, improved synthesis techniques, and the ability to mass-produce high-quality nanomaterials at reduced costs.
Get a Sample PDF Brochure of the Report (Use Corporate Email ID for a Quick Response): https://www.persistencemarketresearch.com/samples/33646
By 2025, the market will reach an estimated valuation of…
Mycotoxin Testing Market Value to Reach US$ 3,268.6 Mn by 2032 Driven by Food Sa …
The global mycotoxin testing market is witnessing robust growth, driven by the increasing need for food safety and quality assurance across agricultural and food production sectors. Valued at US$ 2,145.3 million in 2025, the market is projected to reach approximately US$ 3,268.6 million by 2032, expanding at a steady compound annual growth rate (CAGR) of 6.2% during the forecast period (2025-2032). This growth is primarily attributed to the rising awareness…
More Releases for Phenylbutazone
Phenylbutazone Manufacturing Plant Project Report 2023: Industry Trends, Raw Mat …
IMARC Group's report titled "Phenylbutazone Manufacturing Plant Project Report 2023: Industry Trends, Plant Setup, Machinery, Raw Materials, Investment Opportunities, Cost and Revenue" provides a comprehensive guide for establishing a phenylbutazone manufacturing plant. The report covers various aspects, ranging from a broad market overview to intricate details like unit operations, raw material and utility requirements, infrastructure necessities, machinery requirements, manpower needs, packaging and transportation requirements, and more. In addition to the…
Phenylbutazone Market – Notable Developments, Upcoming Trends & Future Applica …
Global Phenylbutazone Market: Snapshot
The phenylbutazone market has hit a road-block due to its disapproval from the country-wide market in the U.S. However, phenylbutazone, which are nonsteroidal anti-inflammatory drugs (NSAID) that are useful in treating pain, fever, menstrual cramps, arthritis, and other inflammations in human body, continue to be used in other parts of the World. Moreover, these drugs are also used by the veterinary department, wherein 23 actively marketed phenylbutazone…
Global Phenylbutazone Market Huge Growth Opportunity between 2020-2025
LP INFORMATION recently released a research report on the Phenylbutazone market analysis and elaborate the industry coverage, current market competitive status, and market outlook and forecast by 2025. Moreover, it categorizes the global Phenylbutazone market by key players, product type, applications and regions,etc.
The main objective of this market research is to help the readers understand the structure of Phenylbutazone market, market definition, overview, industry opportunities and trends, investment strategy…
Phenylbutazone Market Region-wise Outlook of 2025 - Santa Cruz Biotechnology, In …
Global Phenylbutazone Market: Snapshot
The phenylbutazone market has hit a road-block due to its disapproval from the country-wide market in the U.S. However, phenylbutazone, which are nonsteroidal anti-inflammatory drugs (NSAID) that are useful in treating pain, fever, menstrual cramps, arthritis, and other inflammations in human body, continue to be used in other parts of the World. Moreover, these drugs are also used by the veterinary department, wherein 23 actively marketed phenylbutazone…
Phenylbutazone Market is Expected to Witness Highest Growth During 2017 - 2025
Global Phenylbutazone Market: Snapshot
The phenylbutazone market has hit a road-block due to its disapproval from the country-wide market in the U.S. However, phenylbutazone, which are nonsteroidal anti-inflammatory drugs (NSAID) that are useful in treating pain, fever, menstrual cramps, arthritis, and other inflammations in human body, continue to be used in other parts of the World. Moreover, these drugs are also used by the veterinary department, wherein 23 actively marketed phenylbutazone…
Phenylbutazone Market Detailed Analysis and Forecast by 2025
Global Phenylbutazone Market: Snapshot
The phenylbutazone market has hit a road-block due to its disapproval from the country-wide market in the U.S. However, phenylbutazone, which are nonsteroidal anti-inflammatory drugs (NSAID) that are useful in treating pain, fever, menstrual cramps, arthritis, and other inflammations in human body, continue to be used in other parts of the World. Moreover, these drugs are also used by the veterinary department, wherein 23 actively marketed phenylbutazone…
